Skip to main content
Log in

Initial experience with single-photon emission tomography using iodine-123-labelled 2 β-carbomethoxy-3β-(4-iodophenyl)tropane in human brain

  • Short Communication
  • Published:
European Journal of Nuclear Medicine Aims and scope Submit manuscript

Abstract

The iodinated cocaine analogue 2β-carbomethoxy-3β-(4-iodophenyl)tropane ([123I]β-CIT), a new dopamine transporter, was preliminarily tested in human brain. Two normal volunteers and two patients with Parkinson's disease were imaged with a high-resolution single-photon emission tomography scanner. The specific binding of [123I]β-CIT in the basal ganglia and thalamus was high in normal volunteers. In addition, there was relatively intense uptake in the medial prefrontal area. Patients with Parkinson's disease who were older than controls showed significantly lower specific binding in the basal ganglia and thalamus and no uptake in the medial prefrontal cortex. This decrease in the dopamine transporter may be age related.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Kuhar MJ, Sanchez-Roe PM, Wong DF, et al. Dopamine transporter: biochemistry, pharmacology and imaging. Eur Neurol 1990; 30 Suppl 1:15–20

    Google Scholar 

  2. Laulumaa V, Kuikka JT, Soininen H, Bergström K, Länsimies E, Riekkinen P. Imaging of D-2 dopamine receptors of patients with Parkinson's disease using SPELT and iodine-123-IBZM. Arch Neurol 1993;50:509–512

    Google Scholar 

  3. Mazière B, Mazière M. Where have we got to with neuroreceptor mapping of the human brain. Ear J Nucl Med 1990; 16:817–835

    Google Scholar 

  4. Halldin C, Farde L, Müller L, Karlsson P, Neumeyer JL, Gao Y, Milius R, Hall H, Swahn C-G. Preparation of [11C]β-CIT, a new ligand for imaging cocaine binding sites in vivo by PET. Ear J Nucl Med 1992; 19:592

    Google Scholar 

  5. Costa DC, Verhoeff NPLG, Cullum ID, et al. In vivo characterisation of 3-iodo-6-methoxybenzamide 123I in humans. Eur J Nucl Med 1990; 16:813–816.

    Google Scholar 

  6. Neumeyer JL, Wang S, Milius RA, et al. [123I]2β-carbometh-oxy-3β-(4-iodophenyl)tropane (β-LIT): high affinity SPECT radiotracer of monoamine reuptake sites in brain. J Med Chem 1991;34:3144–3146

    Google Scholar 

  7. Baldwin RM, Zea-Ponce Y, Zoghbi S, et al. Evaluation fo the monoamine uptake site ligand [1131]methyl 3β-(4-iodophenyl)tropane-2β-carboxylate ([123I]β-LIT) in non-human primates: pharmacokinetics, biodistribution, and SPELT brain imaging coregistered with MRI. Nucl Med Biol

  8. Innis R, Baldwin R, Sybirsha E, et al. Single photon emission computed tomography imaging of monoamine reuptake sites in primate brain with [123I]CIT. Ear J Pharmacol 1991; 200:369–3710

    Google Scholar 

  9. Wall SC, Innis RB, Rudnick G. Binding of the cocaine analog 2β-carbomethoxy-3β-(4-125I-iodophenyl)tropane to serotonin and dopamine transporters: different ionic requirements for substrate and 2β-carbomethoxy-2β-(4-125I-iodophenyl)tropane binding. Mol Pharmacol 1993; 43:2–10

    Google Scholar 

  10. Laruelle M, Baldwin RM, Malison RT, et al. SPELT imaging of dopamine and serotonin transporters with [123I]β-CIT: pharmacological characterization of brain uptake in nonhuman primates. Synapse 1993; 13:295–309

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

Correspondence to: J.T. Kuikka

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kuikka, J.T., Bergström, K.A., Vanninen, E. et al. Initial experience with single-photon emission tomography using iodine-123-labelled 2 β-carbomethoxy-3β-(4-iodophenyl)tropane in human brain. Eur J Nucl Med 20, 783–786 (1993). https://doi.org/10.1007/BF00180909

Download citation

  • Revised:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00180909

Key words

Navigation